These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 4374816)
21. Nucleoside triphosphate phosphohydrolase produced in BHK cells infected with western equine encephalitis virus is probably associated with the 82K dalton nonstructural polypeptide. Ishida I; Simizu B; Koizumi S; Oya A; Yamada M Virology; 1981 Jan; 108(1):13-20. PubMed ID: 6115512 [No Abstract] [Full Text] [Related]
22. Virulence heterogeneity of a predominantly avirulent Western equine encephalitis virus population. Jahrling PB J Gen Virol; 1976 Jul; 32(1):121-8. PubMed ID: 956785 [TBL] [Abstract][Full Text] [Related]
23. Inhibition by Agaricus blazei Murill fractions of cytopathic effect induced by western equine encephalitis (WEE) virus on VERO cells in vitro. Sorimachi K; Ikehara Y; Maezato G; Okubo A; Yamazaki S; Akimoto K; Niwa A Biosci Biotechnol Biochem; 2001 Jul; 65(7):1645-7. PubMed ID: 11515550 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of virus multiplication by some derivatives of pyridine- and pyrazinecarboxylic acid. Rada B; Hanusovská T; Palát K; Celadník M; Novácek L Acta Virol; 1971 Jul; 15(4):326-8. PubMed ID: 4398086 [No Abstract] [Full Text] [Related]
25. Infectivity of a multiploid-forming mutant of western equine encephalitis virus. Hashimoto K; Suzuki K; Simizu B Jpn J Med Sci Biol; 1976 Jun; 29(3):165-9. PubMed ID: 978836 [No Abstract] [Full Text] [Related]
26. [Effect of the method of passage on the biological properties of attenuated alphavirus strains]. Tsilinskiĭ IaIa; Prianichnikova LV; Karpova EF; Shablinskaia LM Vopr Virusol; 1984; 29(3):294-301. PubMed ID: 6087563 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of DNA synthesis in BHK cells infected with western equine encephalitis virus. 2. Properties of the inhibitory factor of DNA polymerase induced in infected cells. Koizumi S; Simizu B; Ishida I; Oya A; Yamada M Virology; 1979 Oct; 98(2):439-47. PubMed ID: 228480 [No Abstract] [Full Text] [Related]
28. [Combined use of interferon and various styrylquinolines in cell cultures and experimental arbovirus infections]. Leont'eva NA; Fomina AN; Idrisova ZV; Shubladze AK; Galegov GA Vopr Virusol; 1972; 17(4):482-5. PubMed ID: 5086860 [No Abstract] [Full Text] [Related]
29. The detection of chemical mutagens using the L5178y-Asn-murine leukemia in vitro and in a host-mediated assay. Capizzi RL; Papirmeister B; Mullins JM; Cheng E Cancer Res; 1974 Nov; 34(11):3073-82. PubMed ID: 4370835 [No Abstract] [Full Text] [Related]
30. Assessment of plaque assay methods for alphaviruses. Juarez D; Long KC; Aguilar P; Kochel TJ; Halsey ES J Virol Methods; 2013 Jan; 187(1):185-9. PubMed ID: 23085307 [TBL] [Abstract][Full Text] [Related]
31. Genetic characteristics of mutants of eastern equine encephalomyelitis virus induced by alkylating compounds. Solyanik RG; Fedorov YV; Rapoport IA Sov Genet; 1974 Jun; 8(5):641-4. PubMed ID: 4413560 [No Abstract] [Full Text] [Related]
32. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110 [TBL] [Abstract][Full Text] [Related]
33. Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: eastern equine and western equine encephalitis. Reisler RB; Gibbs PH; Danner DK; Boudreau EF Vaccine; 2012 Nov; 30(50):7271-7. PubMed ID: 23031498 [TBL] [Abstract][Full Text] [Related]
34. [Stimulation of arbovirus reproduction in cell cultures by hormones]. Kokorev VS; Kolotvinova EG Vopr Virusol; 1986; 31(5):623-9. PubMed ID: 3026097 [TBL] [Abstract][Full Text] [Related]
35. Evolutionary genetics and vector adaptation of recombinant viruses of the western equine encephalitis antigenic complex provides new insights into alphavirus diversity and host switching. Allison AB; Stallknecht DE; Holmes EC Virology; 2015 Jan; 474():154-62. PubMed ID: 25463613 [TBL] [Abstract][Full Text] [Related]
36. The influence of cell-free extracts from Ehrlich ascitic carcinoma and Rous sarcoma on the action of antiviral inhibitors. Rada B Acta Virol; 1972 Nov; 16(6):498-500. PubMed ID: 4404902 [No Abstract] [Full Text] [Related]
37. Isolation and preliminary characterization of temperature-sensitive mutants of western equine encephalitis virus. Hashimoto K; Simizu B Virology; 1978 Feb; 84(2):540-3. PubMed ID: 622811 [No Abstract] [Full Text] [Related]
38. Cross-protective immunity between equine encephalomyelitis viruses in equids. Walton TE; Jochim MM; Barber TL; Thompson LH Am J Vet Res; 1989 Sep; 50(9):1442-6. PubMed ID: 2552875 [TBL] [Abstract][Full Text] [Related]
39. Antiviral activities of pyrimidine nucleoside analogues: some structure--activity relationships. Dragún M; Rada B; Novotný L; Beránek J Acta Virol; 1990 Aug; 34(4):321-9. PubMed ID: 1981442 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses. Barber TL; Walton TE; Lewis KJ Am J Vet Res; 1978 Apr; 39(4):621-5. PubMed ID: 646197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]